|
| | Publication Year | Title | Author(s) |
| 341 | 15-May-2016 | Fc-γ Receptor Polymorphisms, Cetuximab Therapy, and Survival in the NCIC CTG CO.17 Trial of Colorectal Cancer. | Liu, Geoffrey; Tu, Dongsheng; Lewis, Marcia; Cheng, Dangxiao; Sullivan, Leslie A; Chen, Zhuo; Morgen, Eric; Simes, John; Price, Timothy J; Tebbutt, Niall C ; Shapiro, Jeremy D; Jeffery, G Mark; Mellor, J Daniel; Mikeska, Thomas; Virk, Shakeel; Shepherd, Lois E; Jonker, Derek J; O'Callaghan, Christopher J ; Zalcberg, John R; Karapetis, Christos S; Dobrovic, Alexander |
| 342 | 7-Dec-2023 | FDG-PET/CT for investigation of pyrexia of unknown origin: a cost of illness analysis. | Liu, Bonnia ; Ma, Ronald ; Shum, Evonne; Hormiz, Maria; Lee, Sze Ting ; Poon, Aurora M T ; Scott, Andrew M |
| 343 | Jul-2020 | FGF13 promotes metastasis of triple-negative breast cancer. | Johnstone, Cameron N ; Pattison, Andrew D; Harrison, Paul F; Powell, David R; Lock, Peter; Ernst, Matthias ; Anderson, Robin L ; Beilharz, Traude H |
| 344 | 27-Feb-2013 | Fine-mapping naturally occurring NY-ESO-1 antibody epitopes in melanoma patients' sera using short overlapping peptides and full-length recombinant protein. | Komatsu, Nobukazu; Jackson, Heather M; Chan, Kok-fei; Oveissi, Sara; Cebon, Jonathan S ; Itoh, Kyogo; Chen, Weisan |
| 345 | 15-Sep-2020 | First clinical study of a pegylated diabody 124I-labeled PEG-AVP0458 in patients with tumor-associated glycoprotein 72 positive cancers. | Scott, Andrew M ; Akhurst, Timothy; Lee, Fook-Thean; Ciprotti, Marika; Davis, Ian D; Weickhardt, Andrew J ; Gan, Hui K ; Hicks, Rodney J; Lee, Sze Ting ; Kocovski, Pece; Guo, Nancy; Oh, Maggie; Mileshkin, Linda; Williams, Scott; Murphy, Declan; Pathmaraj, Kunthi ; O'Keefe, Graeme J; Gong, Sylvia J; Pedersen, John S; Scott, Fiona E; Wheatcroft, Michael P; Hudson, Peter J |
| 346 | Nov-2020 | "First Do No Harm": Significance of Delays from Diagnosis to Surgery in Patients with Non-metastatic Breast Cancer. | Xu, Jennifer; Bromley, Luke; Chew, Grace ; Yeo, Belinda |
| 347 | Dec-2015 | First in human nanotechnology doxorubicin delivery system to target epidermal growth factor receptors in recurrent glioblastoma. | Whittle, James R; Lickliter, Jason D; Gan, Hui K ; Scott, Andrew M ; Simes, John; Solomon, Benjamin J; MacDiarmid, Jennifer A; Brahmbhatt, Himanshu; Rosenthal, Mark A |
| 348 | Apr-2016 | First-in-Man Dose-Escalation Study of the Selective BRAF Inhibitor RG7256 in Patients with BRAF V600-Mutated Advanced Solid Tumors. | Dienstmann, Rodrigo; Lassen, Ulrik; Cebon, Jonathan S ; Desai, Jayesh; Brown, Michael P; Evers, Stefan; Su, Fei; Zhang, Weijiang; Boisserie, Frederic; Lestini, Brian; Schostack, Kathleen; Meresse, Valerie; Tabernero, Josep |
| 349 | Apr-2022 | First-line nivolumab plus ipilimumab combined with two cycles of chemotherapy in advanced non-small cell lung cancer: a subanalysis of Asian patients in CheckMate 9LA. | John, Thomas ; Sakai, Hiroshi; Ikeda, Satoshi; Cheng, Ying; Kasahara, Kazuo; Sato, Yuki; Nakahara, Yoshiro; Takeda, Masayuki; Kaneda, Hiroyasu; Zhang, Helong; Maemondo, Makoto; Minato, Koichi; Hisada, Takeshi; Misumi, Yuki; Satouchi, Miyako; Hotta, Katsuyuki; Li, Ang; Oukessou, Abderrahim; Lu, Shun |
| 350 | Feb-2021 | First-line nivolumab plus ipilimumab combined with two cycles of chemotherapy in patients with non-small-cell lung cancer (CheckMate 9LA): an international, randomised, open-label, phase 3 trial. | Paz-Ares, Luis; Ciuleanu, Tudor-Eliade; Cobo, Manuel; Schenker, Michael; Zurawski, Bogdan; Menezes, Juliana; Richardet, Eduardo; Bennouna, Jaafar; Felip, Enriqueta; Juan-Vidal, Oscar; Alexandru, Aurelia; Sakai, Hiroshi; Lingua, Alejo; Salman, Pamela; Souquet, Pierre-Jean; De Marchi, Pedro; Martin, Claudio; Pérol, Maurice; Scherpereel, Arnaud; Lu, Shun; John, Thomas ; Carbone, David P; Meadows-Shropshire, Stephanie; Agrawal, Shruti; Oukessou, Abderrahim; Yan, Jinchun; Reck, Martin |
| 351 | 1-Oct-2021 | First-line nivolumab plus ipilimumab with two cycles of chemotherapy versus chemotherapy alone (four cycles) in advanced non-small-cell lung cancer: CheckMate 9LA 2-year update. | Reck, M; Ciuleanu, T-E; Cobo, M; Schenker, M; Zurawski, B; Menezes, J; Richardet, E; Bennouna, J; Felip, E; Juan-Vidal, O; Alexandru, A; Sakai, H; Lingua, A; Reyes, F; Souquet, P-J; De Marchi, P; Martin, C; Pérol, M; Scherpereel, A; Lu, S; Paz-Ares, L; Carbone, D P; Memaj, A; Marimuthu, S; Zhang, X; Tran, P; John, Thomas |
| 352 | 28-Jan-2023 | First-line nivolumab plus ipilimumab with two cycles of chemotherapy versus chemotherapy alone (four cycles) in metastatic non-small cell lung cancer: CheckMate 9LA 2-year patient-reported outcomes. | Reck, Martin; Ciuleanu, Tudor-Eliade; Cobo, Manuel; Schenker, Michael; Zurawski, Bogdan; Menezes, Juliana; Richardet, Eduardo; Bennouna, Jaafar; Felip, Enriqueta; Juan-Vidal, Oscar; Alexandru, Aurelia; Cheng, Ying; Sakai, Hiroshi; Paz-Ares, Luis; Lu, Shun; John, Thomas ; Sun, Xiaowu; Moisei, Aniela; Taylor, Fiona; Lawrance, Rachael; Zhang, Xiaoqing; Sylvester, Judi; Yuan, Yong; Blum, Steven I; Penrod, John R; Carbone, David P |
| 353 | Aug-2016 | Fluorine-18 radiolabeling of a nitrophenyl sulfoxide and its evaluation in an SK-RC-52 model of tumor hypoxia | Laurens, Evelyn; Yeoh, Shin Dee; Rigopoulos, Angela; O'Keefe, Graeme J; Tochon-Danguy, Henri J ; Chong, Lee Wenn; White, Jonathan M; Scott, Andrew M ; Ackermann, Uwe |
| 354 | 15-Jan-2014 | FOXP3 over-expression inhibits melanoma tumorigenesis via effects on proliferation and apoptosis. | Tan, BeeShin; Anaka, Matthew; Deb, Siddhartha; Freyer, Claudia; Ebert, Lisa M; Chueh, Anderly C; Al-Obaidi, Sheren; Behren, Andreas; Jayachandran, Aparna; Cebon, Jonathan S ; Chen, Weisan; Mariadason, John M |
| 355 | Apr-2018 | Fresh Frozen Plasma Transfusion Can Confound the Analysis of Circulating Cell-Free DNA. | Goh, Su Kah ; Muralidharan, Vijayaragavan ; Christophi, Christopher ; Dobrovic, Alexander |
| 356 | 1-Mar-2019 | Frizzled-7 Is Required for Wnt Signaling in Gastric Tumors with and Without Apc Mutations. | Flanagan, Dustin J; Barker, Nick; Costanzo, Natasha S Di; Mason, Elizabeth A; Gurney, Austin; Meniel, Valerie S; Koushyar, Sarah; Austin, Chloe R; Ernst, Matthias ; Pearson, Helen B; Boussioutas, Alex; Clevers, Hans; Phesse, Toby J; Vincan, Elizabeth |
| 357 | 7-Jan-2014 | Fully automated synthesis and coupling of [(18) F]FBEM to glutathione using the iPHASE FlexLab module. | Ackermann, Uwe ; Plougastel, Lucie; Wichmann, Christian; Goh, Yit Wooi; Yeoh, Shinn Dee; Poniger, Stan S; Tochon-Danguy, Henri J ; Scott, Andrew M |
| 358 | Aug-2016 | Fully automated synthesis of [(18) F]fluoro-dihydrotestosterone ([(18) F]FDHT) using the FlexLab module | Ackermann, Uwe ; Lewis, Jason S; Young, Kenneth ; Morris, Michael J; Weickhardt, Andrew; Davis, Ian D; Scott, Andrew M |
| 359 | 12-Mar-2023 | Fully human monoclonal antibody targeting activated ADAM10 on colorectal cancer cells. | Saha, Nayanendu; Baek, Du-San; Mendoza, Rachelle P; Robev, Dorothea; Xu, Yan; Goldgur, Yehuda; De La Cruz, M Jason; de Stanchina, Elisa; Janes, Peter W ; Xu, Kai; Dimitrov, Dimiter S; Nikolov, Dimitar B |
| 360 | 30-Apr-2018 | Functional and genomic characterisation of a xenograft model system for the study of metastasis in triple-negative breast cancer. | Johnstone, Cameron N ; Pattison, Andrew D; Gorringe, Kylie L; Harrison, Paul F; Powell, David R; Lock, Peter; Baloyan, David; Ernst, Matthias ; Stewart, Alastair G; Beilharz, Traude H; Anderson, Robin L |
